Active Pharmaceutical Ingredients (API): Global Markets Estimated to Reach 154.7 billion by 2022

| June 18, 2018

article image
This report (Active Pharmaceutical Ingredients: Global Markets to 2022) covers an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing trends and regulatory guidelines that impact the procurement of API are studied here. The increasing importance of API outsourced manufacturing activities and the impact on the pharmaceutical industry are covered in the report. The API market is segmented into categories: molecular entity, manufacturer type, end use and region. The API market is segmented into two molecular entity groups: natural and synthetic API. Synthetic APIs are further segmented into chemical synthesis, biocatalytic and cell culture. Under the category of molecular entity, APIs are segmented into small molecules and large molecules. By sourcing type, the market is segmented into captive market, merchant market and contract manufacturing organization (CMO). In terms of end use, the market is segmented into clinical trial use and commercial use.

Spotlight

Pharmaceutical Solutions Industry Ltd "PSI"​

Dedicated to the development and manufacturing of pharmaceutical solutions with international quality standards, Pharmaceutical Solutions Industry Ltd. is a fully integrated pharmaceutical company thriving on a culture of innovation and excellence. 

 Pharmaceutical Solutions Industry is the leading, and the largest producer of a wide range of sterile IV solutions in the MENA region. 

Headquartered in Jeddah, Saudi Arabia, PSI has successfully grown to expand its portfolio catering to the needs of both domestic and international markets. 

As one of the Arab world's pioneering pharmaceutical companies, we are committed to providing the global healthcare market with life saving solutions. 

 PSI philosophy on the pharmaceutical production is that world competitive results can only be obtained with the best people, processes and technology. 

 With a workforce of 600 employees in addition to several full time consultants, PSI paves its way from planning to production for the quality, sa

OTHER ARTICLES

WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST

Article | February 11, 2020

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fill prescriptions for Fentanyl, morphine, and other painkillers. Le pleaded guilty to multiple felony impersonation counts. Walgreen’s agreed to the settlement to avoid being charged with consumer fraud in Alameda and Santa Anna Counties. Prosecutors alleged that Walgreen’s failed to verify Le’s license and did not conduct a thorough background check. The company insisted it has taken remedial measures.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | April 9, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 6, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?

Article | April 1, 2020

Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. The U.S. is now the coronavirus epicenter, with the most cases -- more than 161,000 as of today. Initial concerns for drugmakers had to do with the supply of active pharmaceutical ingredients, which often come from China. The worry was that pharmaceutical companies wouldn't be able to produce enough of their drugs for patients.

Read More

Spotlight

Pharmaceutical Solutions Industry Ltd "PSI"​

Dedicated to the development and manufacturing of pharmaceutical solutions with international quality standards, Pharmaceutical Solutions Industry Ltd. is a fully integrated pharmaceutical company thriving on a culture of innovation and excellence. 

 Pharmaceutical Solutions Industry is the leading, and the largest producer of a wide range of sterile IV solutions in the MENA region. 

Headquartered in Jeddah, Saudi Arabia, PSI has successfully grown to expand its portfolio catering to the needs of both domestic and international markets. 

As one of the Arab world's pioneering pharmaceutical companies, we are committed to providing the global healthcare market with life saving solutions. 

 PSI philosophy on the pharmaceutical production is that world competitive results can only be obtained with the best people, processes and technology. 

 With a workforce of 600 employees in addition to several full time consultants, PSI paves its way from planning to production for the quality, sa

Events